Literature DB >> 14725599

Do olfactory reference syndrome and jiko-shu-kyofu (a subtype of taijin-kyofu) share a common entity?

K Suzuki1, N Takei, Y Iwata, Y Sekine, T Toyoda, K Nakamura, Y Minabe, M Kawai, M Iyo, N Mori.   

Abstract

OBJECTIVE: Olfactory reference syndrome (ORS) in the Western literature is characterized as preoccupation with the idea that the body emits a foul odor. Japanese patients with a feature similar to ORS have long been recognized as jiko-shu-kyofu, which is believed to be a culture-bound syndrome and specific to Japan. The aim of the study was to clarify the relationship between the two separate syndromes that had independently been recognized in culturally different settings.
METHOD: The phenomenology and treatment of seven patients with jiko-shu-kyofu were described. A feature of jiko-shu-kyofu was then compared with that of ORS.
RESULTS: In our cases, clinical characteristics of jiko-shu-kyofu such as symptomatology, insight, and pharmacotherapy response were found identical to those of ORS except for the onset at relatively younger ages.
CONCLUSION: Jiko-shu-kyofu and ORS may share a common clinical entity, hence the former is not a culturally distinctive disorder.

Entities:  

Mesh:

Year:  2004        PMID: 14725599     DOI: 10.1046/j.1600-0447.2003.00195.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  7 in total

Review 1.  Olfactory reference syndrome: issues for DSM-V.

Authors:  Jamie D Feusner; Katharine A Phillips; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  Olfactory reference syndrome: demographic and clinical features of imagined body odor.

Authors:  Katharine A Phillips; William Menard
Journal:  Gen Hosp Psychiatry       Date:  2011-05-26       Impact factor: 3.238

3.  Is olfactory reference syndrome an OCD?

Authors:  Gurvinder Pal Singh
Journal:  Indian J Psychiatry       Date:  2006-07       Impact factor: 1.759

4.  Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders.

Authors:  Geoffrey M Reed; Michael B First; Cary S Kogan; Steven E Hyman; Oye Gureje; Wolfgang Gaebel; Mario Maj; Dan J Stein; Andreas Maercker; Peter Tyrer; Angelica Claudino; Elena Garralda; Luis Salvador-Carulla; Rajat Ray; John B Saunders; Tarun Dua; Vladimir Poznyak; María Elena Medina-Mora; Kathleen M Pike; José L Ayuso-Mateos; Shigenobu Kanba; Jared W Keeley; Brigitte Khoury; Valery N Krasnov; Maya Kulygina; Anne M Lovell; Jair de Jesus Mari; Toshimasa Maruta; Chihiro Matsumoto; Tahilia J Rebello; Michael C Roberts; Rebeca Robles; Pratap Sharan; Min Zhao; Assen Jablensky; Pichet Udomratn; Afarin Rahimi-Movaghar; Per-Anders Rydelius; Sabine Bährer-Kohler; Ann D Watts; Shekhar Saxena
Journal:  World Psychiatry       Date:  2019-02       Impact factor: 49.548

Review 5.  Olfactory Reference Disorder: Diagnosis, Epidemiology and Management.

Authors:  Eileen Thomas; Stéfan du Plessis; Bonginkosi Chiliza; Christine Lochner; Dan Stein
Journal:  CNS Drugs       Date:  2015-12       Impact factor: 5.749

Review 6.  Diagnosis of Human Axillary Osmidrosis by Genotyping of the Human ABCC11 Gene: Clinical Practice and Basic Scientific Evidence.

Authors:  Yu Toyoda; Tsuneaki Gomi; Hiroshi Nakagawa; Makoto Nagakura; Toshihisa Ishikawa
Journal:  Biomed Res Int       Date:  2016-02-23       Impact factor: 3.411

7.  Diagnosis and phenotypic assessment of trimethylaminuria, and its treatment with riboflavin: 1H NMR spectroscopy and genetic testing.

Authors:  Nadia Bouchemal; Lisa Ouss; Anaïs Brassier; Valérie Barbier; Stéphanie Gobin; Laurence Hubert; Pascale de Lonlay; Laurence Le Moyec
Journal:  Orphanet J Rare Dis       Date:  2019-09-18       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.